MAOB and Parkinson disease: MAO-B is considered to be associated with neuronal death caused by oxidative stress and neurotoxin synthesis as seen in Parkinson’s disease; MAO-B inhibitors, rasagiline and selegiline [(-)deprenyl], protect neurons in animal and cellular models of neurodegeneration [32].